NEW YORK, July 23 – GeneMachines has licensed two patents covering microarray fabrication technology from Incyte Genomics, the company said Monday.
The license will allow GeneMachines, based in San Carlos, Calif., to sell its microarray printing machines, the OmniGrid and OmniGrid Accent, with label licenses for research use. In a statement, the company made no mention of any changes to their microarraying products, which have been available to customers for several years.
Financial details were not disclosed.
The patents cover basic contact microarray printing technology for arraying DNA microarrays on solid substrates, GeneMachines said.
“We are excited to have worldwide licensing rights to this enabling technology which has become invaluable to genomics research," Scott Hunicke-Smith, CEO of GeneMachines, said in a statement.